Single-Cell Analysis Transcriptomics Market Size Projected To Reach 1.74 Billion By 2034 With A Cagr Of 12.4%

"Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Projected Growth of the Single-Cell Analysis Transcriptomics Market?
The market size for single-cell analysis transcriptomics has seen a significant upturn in the past few years. It's anticipated to expand from $0.97 billion in 2024 to $1.09 billion in 2025, marking a compound annual growth rate (CAGR) of 12.7%. Factors such as the escalating demand for personalized medicine, a higher incidence of chronic and rare diseases, the advent of personalized medicine, a growing need for high-throughput sequencing, and greater applications in cancer research are deemed responsible for the growth during the historic period.

The market size for single-cell analysis transcriptomics is forecasted to experience significant growth in the forthcoming years, with a size of $1.74 billion predicted for 2029 and a compound annual growth rate (CAGR) of 12.4%. Factors contributing to this growth during the projected period include an increased application in the fields of immunology and neurology, its soaring use in the discovery and development of drugs, greater acceptance of precision medicine, government-led initiatives backing genomics research, and the increased affordability of sequencing technologies. Key trends likely during the projected period include the progression in microfluidics and sequencing platforms, the incorporation of artificial intelligence into data analysis, the rise of multi-omics approaches, the introduction of innovative single-cell isolation techniques, and an increased emphasis on spatial transcriptomics.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24400&type=smp

What Are the Different Single-Cell Analysis Transcriptomics Market Segments?
The single-cell analysis transcriptomics market covered in this report is segmented -

1) By Component: Equipment, Consumables, Software And Services
2) By Technology: Single-Cell Ribonucleic Acid (RNA) Sequencing, Microfluidics-Based Techniques, Other Technologies
3) By Application: Clinical Diagonstics, Developmental Biology, Drug Discovery, Other Applications
4) By End-User: Academic And Research Institutions, Hospitals And Diagonstic Centers, Pharmaceutical And Biotechnology Companies

Subsegments:
1) By Equipment: Ribonucleic Acid (RNA) Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems
2) By Consumables: Reagents And Kits, Ribonucleic Acid (RNA) Extraction Kits, Microarray Chips, Sequencing Chips, Complementary DNA (cDNA) Synthesis Kits, Library Preparation Kits, Enzymes And Buffers
3) By Software And Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support And Training

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24400&type=smp

What Are the Primary Drivers Shaping the Single-Cell Analysis Transcriptomics Market?
The growth of the single-cell analysis transcriptomics market is anticipated to get a significant boost with the rising acceptance of personalized medicine. Personalized medicine tailors treatments to individuals' genetic profiles, lifestyle, and environmental factors. This growing popularity is due to advances in genetic sequencing that enable treatment modifications according to unique genetic makeups for heightened effectiveness. Personalized treatments are guided by single-cell analysis transcriptomics, which reveal individual gene expression profiles based on a patient's distinct biology. This enhances the efficacy of treatments, reduces side effects, and facilitates early disease detection. For example, in February 2024, the U.S. Food and Drug Administration gave its approval for 16 new personalized treatments for rare diseases, up from six in 2022, according to the Personalized Medicine Coalition, a US-based healthcare organization and hospital. Thus, the heightened adoption of personalized medicine is a key driver in driving the growth of the single-cell analysis transcriptomics market.

Which Companies Are Leading in the Single-Cell Analysis Transcriptomics Market?
Major companies operating in the single-cell analysis transcriptomics market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., Relation Therapeutics Ltd., CYTENA GmbH, Fluent BioSciences

What Are the Latest Developing Trends in the Single-Cell Analysis Transcriptomics Market?
Leading organizations in the single-cell analysis transcriptomics market are concentrating on creating novel products, like single-cell RNA sequencing kits, to enhance workflows and offer a deeper perspective on cellular diversity. This particular type of kit is designed to isolate and scrutinize gene expression on a cellular level, giving research professionals the ability to discover cellular variety and understand intricate biological operations. For instance, Fluent BioSciences Inc., a U.S. biotech firm expert in single-cell examination and molecular research innovations, introduced the PIPseq T2 and T20 v3.0 kits in June 2022. These kits can capture anywhere from 2,000 up to 20,000 single cells or nuclei per reaction. They provide a delicate, scalable, and flexible transcriptomic analysis that is ideal for studies with low-cell diversity and broad-scale solid tissue profiling. Additionally, it's also a highly accessible and cost-efficient single-cell RNA sequencing kit.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-transcriptomics-global-market-report

What Are the Top Revenue-Generating Geographies in the Single-Cell Analysis Transcriptomics Market?
North America was the largest region in the single-cell analysis transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell analysis transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Single-Cell Analysis Transcriptomics Market?
2. What is the CAGR expected in the Single-Cell Analysis Transcriptomics Market?
3. What Are the Key Innovations Transforming the Single-Cell Analysis Transcriptomics Industry?
4. Which Region Is Leading the Single-Cell Analysis Transcriptomics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.

Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.

This release was published on openPR.